BIOMAT Database Logo BIOMAT Database Logo

Comparison of intramuscular iron-dextran and oral ferrous sulfate in the treatment of iron-deficiency anemia. 1959

W L YU, and K MANONMANI, and R J WATSON

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003911 Dextrans A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes. Dextran,Dextran 40,Dextran 40000,Dextran 70,Dextran 75,Dextran 80,Dextran B-1355,Dextran B-1355-S,Dextran B1355,Dextran B512,Dextran Derivatives,Dextran M 70,Dextran T 70,Dextran T-40,Dextran T-500,Hemodex,Hyskon,Infukoll,Macrodex,Polyglucin,Promit,Rheodextran,Rheoisodex,Rheomacrodex,Rheopolyglucin,Rondex,Saviosol,Dextran B 1355,Dextran B 1355 S,Dextran T 40,Dextran T 500
D005296 Ferrous Compounds Inorganic or organic compounds that contain divalent iron. Compounds, Ferrous
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000740 Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. Anemias
D000747 Anemia, Hypochromic Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393) Chlorosis,Anemias, Hypochromic,Chloroses,Hypochromic Anemia,Hypochromic Anemias

Related Publications

W L YU, and K MANONMANI, and R J WATSON
Intramuscular iron-dextran in the treatment of iron deficiency anemia of pregnancy.
January 1960, Quarterly bulletin. Northwestern University (Evanston, Ill.). Medical School,
W L YU, and K MANONMANI, and R J WATSON
Ferrous sulfate liquid for the treatment of iron deficiency anemia.
January 1981, Paediatrica Indonesiana,
W L YU, and K MANONMANI, and R J WATSON
Comparison of ferrous sulfate, polymaltose complex and iron-zinc in iron deficiency anemia.
October 2019, Minerva pediatrica,
W L YU, and K MANONMANI, and R J WATSON
Comparison of ferrous sulfate and ferrous glycinate chelate for the treatment of iron deficiency anemia in gastrectomized patients.
January 2008, Nutrition (Burbank, Los Angeles County, Calif.),
W L YU, and K MANONMANI, and R J WATSON
Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate.
September 2012, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
W L YU, and K MANONMANI, and R J WATSON
Comparison of intravenous ferrous sucrose and oral ferrous sulphate in treatment of postpartum iron deficiency anemia.
April 2017, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
W L YU, and K MANONMANI, and R J WATSON
A comparative study between intramuscular iron dextran and oral ferrous sulphate in the treatment of iron deficiency anaemia in pregnancy.
November 2003, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
W L YU, and K MANONMANI, and R J WATSON
[Ferrous sulfate in the treatment of iron deficiency anemia: The positions continue].
January 2017, Terapevticheskii arkhiv,
W L YU, and K MANONMANI, and R J WATSON
The gastrointestinal absorption of oral iron-dextran and ferrous sulfate.
October 1961, The American journal of the medical sciences,
W L YU, and K MANONMANI, and R J WATSON
[Treatment of iron deficiency anemia with ferrous sulfate in methacrylate "sponge"].
January 1967, Archivos del Instituto de Cardiologia de Mexico,
Copied contents to your clipboard!